Ironwood Pharmaceuticals ...
3.65
-0.12 (-3.18%)
At close: Jan 14, 2025, 3:59 PM
3.65
-0.14%
After-hours Jan 14, 2025, 04:38 PM EST

Ironwood Pharmaceuticals Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020
Collaborative arrangement, collaboration and license agreements Revenue 413.00K 368.00K 121.00K 91.00K 151.00K 144.00K 148.00K 192.00K 114.00K 219.00K 200.00K 100.00K 300.00K 200.00K 200.00K
Collaborative arrangement, collaboration and license agreements Revenue Growth +12.23% +204.13% +32.97% -39.74% +4.86% -2.70% -22.92% +68.42% -47.95% +9.50% +100.00% -66.67% +50.00% 0.00% n/a
Royalty Revenue 700.00K 516.00K n/a 580.00K 570.00K 365.00K 409.00K 480.00K 396.00K 547.00K 408.00K n/a n/a n/a n/a
Royalty Revenue Growth +35.66% n/a n/a +1.75% +56.16% -10.76% -14.79% +21.21% -27.61% +34.07% n/a n/a n/a n/a n/a
Collaborative arrangement, other agreements Revenue 222.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Collaborative arrangement, other agreements Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Europe And Other Revenue 2.80M 2.40M 2.60M 2.30M 2.16M
Europe And Other Revenue Growth +16.67% -7.69% +13.09% +6.34% n/a
North America Revenue 433.24M 2.73M 2.71M n/a n/a
North America Revenue Growth +15763.86% +0.63% n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 36.11M 36.96M 37.60M 37.57M 36.05M 52.48M 31.12M 28.39M 28.62M 30.12M 28.86M 28.69M 27.74M 27.05M 27.65M 33.98M 34.93M 34.64M 36.45M 39.19M 40.92M 43.25M 64.74M 58.18M 55.25M 68.36M 61.92M 57.95M 61.77M 57.79M 55.60M 55.21M 44.99M 36.92M 36.17M 31.51M 30.44M 32.95M 30.35M
Selling, General, and Administrative Revenue Growth -2.30% -1.70% +0.10% +4.22% -31.32% +68.67% +9.61% -0.80% -5.00% +4.38% +0.61% +3.41% +2.55% -2.17% -18.63% -2.71% +0.82% -4.96% -6.99% -4.23% -5.38% -33.20% +11.28% +5.31% -19.18% +10.40% +6.85% -6.19% +6.89% +3.93% +0.72% +22.72% +21.86% +2.07% +14.79% +3.51% -7.63% +8.60% n/a
Research and Development Revenue 29.83M 29.88M 25.30M 35.06M 32.98M 1.13B 12.85M 10.45M 11.54M 11.45M 10.82M 31.85M 10.91M 12.16M 15.48M 16.27M 21.69M 22.08M 28.03M 26.54M 27.55M 28.76M 53.99M 44.27M 46.79M 38.93M 36.51M 40.12M 37.06M 37.34M 33.70M 38.44M 37.53M 31.68M 31.84M 27.63M 25.83M 28.65M 26.64M
Research and Development Revenue Growth -0.18% +18.10% -27.84% +6.30% -97.07% +8657.11% +22.98% -9.52% +0.81% +5.82% -66.02% +192.02% -10.33% -21.45% -4.81% -25.01% -1.74% -21.23% +5.61% -3.68% -4.20% -46.73% +21.95% -5.39% +20.19% +6.65% -9.00% +8.23% -0.75% +10.81% -12.33% +2.44% +18.45% -0.50% +15.26% +6.96% -9.84% +7.53% n/a

Create Price Alert on IRWD

Your price alert will notify you when the stock price is above 3.65.

Add to Watchlist